ZUMZ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ZUMZ is not a good buy right now. Price action is weak (bearish MACD, RSI ~38, price below pivot), options flow is aggressively put-skewed, and insiders are selling heavily. Despite a strong 2026/Q3 earnings rebound, the near-term setup favors downside or at best a choppy base—an impatient buyer is more likely to get a worse entry than upside follow-through.
Trend/price levels: ZUMZ closed at 24.53, below the pivot (24.975), indicating near-term weakness. Immediate support is S1 at 24.022 (then S2 at 23.433). Overhead resistance is R1 at 25.928 (then R2 at 26.517). Momentum: MACD histogram is negative (-0.0811) but contracting, suggesting bearish momentum is easing, not reversing. RSI(6) at 38.45 is weak/near oversold but not signaling a confirmed turn. Moving averages are converging, consistent with consolidation after weakness rather than a fresh uptrend. Quant pattern read: similar-pattern projection implies modest downside risk over 1W/1M (-2.43% week, -7.18% month).
Intellectia Proprietary Trading Signals
Strong 2026/Q3 results: revenue +7.49% YoY, net income +690% YoY, EPS +816.67% YoY, and gross margin improvement (+6.68% YoY). Analyst noted recovery in the skate category, supporting the B. Riley price-target lift.
Insiders are selling and the selling amount increased ~265% over the last month. Options market is strongly bearish by volume (put/call volume 18.0). Short-term statistical trend projection points to weakness over the next week/month.
Latest quarter: 2026/Q3. Growth improved meaningfully: revenue rose to $239.132M (+7.49% YoY) while profitability surged (net income $9.16M, +690% YoY; EPS $0.55, +816.67% YoY). Gross margin expanded to 37.55% (+6.68% YoY), indicating better pricing/merchandising and/or lower costs. Fundamentally strong quarter, but the market is currently trading more on forward (Q4) moderation and sentiment.
Most recent update (2025-12-05): B. Riley raised price target to $24 from $18 and maintained a Neutral rating. Pros: acknowledged Q3 beat and skate-category recovery. Cons: expects moderating trends in Q4; Neutral rating implies limited conviction in near-term upside. With the stock around ~$24.5, it is already near/above that $24 target, limiting upside per that view.
